HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Devasis Chatterjee Selected Research

2- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamide

1/2014Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Devasis Chatterjee Research Topics

Disease

14Neoplasms (Cancer)
08/2015 - 01/2004
6Prostatic Neoplasms (Prostate Cancer)
01/2015 - 08/2004
6Neoplasm Metastasis (Metastasis)
01/2014 - 10/2007
3Breast Neoplasms (Breast Cancer)
01/2014 - 04/2004
2Stomach Neoplasms (Stomach Cancer)
01/2014 - 01/2012
2Adenocarcinoma
01/2014 - 05/2008
1Colorectal Neoplasms (Colorectal Cancer)
08/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2015
1Carcinoma (Carcinomatosis)
10/2013
1Colonic Neoplasms (Colon Cancer)
10/2013
1Melanoma (Melanoma, Malignant)
12/2012
1Lung Neoplasms (Lung Cancer)
06/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2004

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
08/2015 - 01/2004
6Proteins (Proteins, Gene)FDA Link
01/2015 - 10/2007
5Phosphatidylethanolamine Binding ProteinIBA
01/2014 - 10/2007
3CytokinesIBA
01/2015 - 01/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2004
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2014 - 05/2008
3CamptothecinIBA
10/2013 - 08/2004
3raf KinasesIBA
01/2013 - 05/2008
2Messenger RNA (mRNA)IBA
01/2015 - 01/2013
2Biomarkers (Surrogate Marker)IBA
01/2015 - 10/2013
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 10/2013
2Proto-Oncogene Proteins c-rafIBA
01/2013 - 10/2007
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2012 - 05/2008
2AntibodiesIBA
11/2010 - 01/2004
2NF-kappa B (NF-kB)IBA
09/2008 - 10/2007
1Paclitaxel (Taxol)FDA LinkGeneric
01/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2015
1MicroRNAs (MicroRNA)IBA
01/2015
1Phosphotransferases (Kinase)IBA
01/2014
12- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamideIBA
01/2014
1AgarIBA
10/2013
1ProhibitinsIBA
10/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2013
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2013
1Progesterone Receptors (Progesterone Receptor)IBA
01/2013
1ClaudinsIBA
01/2013
1Estrogens (Estrogen)FDA Link
01/2013
1Phenobarbital (Luminal)FDA Link
01/2013
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
12/2012
1SynteninsIBA
12/2012
1Indicators and Reagents (Reagents)IBA
06/2011
1Conditioned Culture MediaIBA
11/2010
12,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA
09/2008
1Nitric Oxide DonorsIBA
09/2008
1Transcription Factors (Transcription Factor)IBA
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007
1LigandsIBA
10/2007
1Death Domain ReceptorsIBA
10/2007
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2007
1Oncostatin MIBA
01/2005
1Rituximab (Mabthera)FDA Link
10/2004
1Antineoplastic Agents (Antineoplastics)IBA
09/2004
1taurolidineIBA
09/2004
1Small Interfering RNA (siRNA)IBA
04/2004
1Oncogene Proteins (Oncogene Protein)IBA
04/2004

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2015 - 09/2008
3Therapeutics
01/2015 - 01/2004
2Aftercare (After-Treatment)
10/2013 - 04/2004
2Immunotherapy
09/2008 - 01/2004